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The Avon Longitudinal Study of Parents and Children (ALSPAC) is a 
prospective population-based cohort study which recruited pregnant 
women in 1990-1992 and has followed these women, their partners 
(Generation 0; G0) and their offspring (Generation 1; G1) ever since. 
The study has reacted rapidly and repeatedly to the coronavirus 
disease 2019 (COVID-19) pandemic, deploying online questionnaires 
throughout the pandemic. In November/December 2020, a fourth 
questionnaire was deployed asking about physical and mental health, 
lifestyle and behaviours, employment and finances. 
G0 participants were offered an online questionnaire between 17th 
November 2020 and 7th February 2021, while G1 participants were 
offered both online and paper questionnaires between 1st December 
2020 and 19th March 2021. Of 15,844 invitations, 8,643 (55%) 
participants returned the questionnaire (3,101 original mothers [mean 
age 58.6 years], 1,172 original fathers/partners [mean age 61.5 years] 
and 4,370 offspring [mean age 28.4 years]). Of these 8,643 
participants, 2,012 (23%) had not returned a previous COVID-19 
questionnaire, while 3,575 (41%) had returned all three previous 
questionnaires. 
In this questionnaire, 300 participants (3.5%) reported a previous 
positive COVID-19 test, 110 (1.3%) had been told by a doctor they likely 
had COVID-19, and 759 (8.8%) suspected that they had had COVID-19. 
Based on self-reported symptoms, between October 2020 and 
February 2021 359 participants (4.2%) were predicted COVID-19 cases. 
COVID data is being complemented with linkage to health records and 
Public Health England pillar testing results as they become available. 
Data has been released as an update to the previous COVID-19 
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datasets. It comprises: 1) a standard dataset containing all participant 
responses to both questionnaires with key sociodemographic factors; 
and 2) as a composite release coordinating data from the existing 
resource, thus enabling bespoke research across all areas supported 
by the study. This data note describes the fourth questionnaire and 
the data obtained from it.
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Introduction
At the time of writing (May 2021), we are over a year into the 
coronavirus disease 2019 (COVID-19) pandemic. The global 
impact has been considerable, with over 165 million confirmed 
cases – and over three million deaths – to date (WHO COVID-19 
Dashboard). Despite the roll-out of vaccines, many coun-
tries are still under some form of restrictions, including local or 
national lockdowns. In the UK, mitigation strategies against the 
COVID-19 pandemic have changed repeatedly since March 
2020, from an initial comprehensive set of restrictions on normal 
life (termed the ‘lockdown’) which took effect on March 
23rd 2020, to easing throughout summer 2020, followed by more 
targeted ‘local’ restrictions in Autumn 2020, back to second (in 
November 2020) and third (from early January 2021) nation-
wide lockdowns (with differing rules in different UK nations). 
More detailed information on the COVID timeline in the UK 
can be viewed here. Since 29th March 2021, a gradual lifting 
of the restrictions has been introduced in the UK, such as a 
return to school and groups of up to six people being allowed to 
meet outdoors (whilst adhering to social distancing).
The impact of the COVID-19 pandemic and its management, 
including continuing restrictions, has lasted over a year; the 
long-term impact of COVID-19 on current and future employ-
ment, physical and mental health, financial activity and personal 
relationships is therefore likely to be substantial. It is vital that 
longitudinal, population-based studies continue to prospec-
tively measure the impact of lockdowns and various manage-
ment strategies on their participants. Such studies are needed to 
understand the ongoing effects of mitigation strategies on health 
and well-being1 and identifying inequalities in response to 
the pandemic2.
The Avon Longitudinal Study of Parents and Children (ALSPAC) 
is a unique three-generational study, comprising ‘G0’: the cohort 
of original pregnant women and the fathers/partners of these 
women; ‘G1’: the cohort of index children; and ‘G2’: the cohort 
of offspring of the index children. The study has a wealth of bio-
logical, genetic and phenotypic data across these generations3–6. 
ALSPAC has been well placed to capture information across 
key parts of the population during the COVID-19 pandemic – in 
particular the contrast between those in higher risk (the G0 
cohort; mean age ~59 years) and lower risk (the G1 cohort; mean 
age ~28 years) groups. We have been able to collect repeat data 
quickly using our existing infrastructure for online data collec-
tion. So far, ALSPAC has conducted three COVID-19 question-
naires using G0 and G1 data: the first between 9th April to 15th 
May 20207, the second between 26th May to 5th July 20208; and 
the third, with an antibody test, between 3rd and 20th October 
20209. As part of the second questionnaire, parents of G2 
children also completed a questionnaire for each of their 
children10.
The wider COVID-19 data collection in ALSPAC will 
include data from three main sources: self-reported data from 
questionnaires, data from clinical services based on linkage 
to medical and other records (such as Public Health England 
Pillar testing11) and information from biological samples. The 
data from these sources are intended to be complementary 
and help address different potential research questions around 
COVID-19.
This data note describes the data collected via our fourth ques-
tionnaire between 17th November 2020 and 19th March 2021 
and provides a summary of the participants who responded.
The update to the datasets obtained from our previous 
questionnaires7–9 is described here, together with any variables 
that have been derived using multiple sets of questionnaire data. 
We also present a brief assessment of the factors associated with 
returning the fourth COVID questionnaire, but not any of the 




ALSPAC is an intergenerational longitudinal cohort that 
recruited pregnant women residing in Avon, UK with expected 
dates of delivery 1st April 1991 to 31st December 19923,4. The 
initial cohort consisted of 14,541 pregnancies resulting in 
14,062 live births and 13,988 children who were alive at one 
year of age. From the age of seven onwards, the initial sample 
was bolstered with eligible cases who had originally failed to 
join the study and there were subsequently 14,901 children alive 
at one year of age following this further recruitment5. Please 
note, the study website contains details of all the data that is 
available through a fully searchable data dictionary and variable 
search tool.
In response to the COVID-19 pandemic it was necessary to 
develop a data collection strategy which was practical, would 
yield data quickly and could be updated and repeated if neces-
sary. For these reasons, we initially chose to use an online-only 
data collection approach for this, restricting our invites to those 
participants with a valid email address (and coordinated with 
a systematic communications/outreach campaign to obtain 
updated information from participants). For the fourth COVID-19 
questionnaire, G0 data collection was again online-only. 
However, for G1 participants this COVID questionnaire was 
embedded within the wider ‘Life@28’ questionnaire as part of 
ALSPAC’s annual questionnaire strategy; this questionnaire 
was therefore available to G1 participants in both online and 
paper formats. This meant that, unlike previous questionnaires, 
G1 participants without a valid email address were sent a physi-
cal invitation letter through the post. For G0 participants, invites 
were only sent to those with a valid email address. The online 
questionnaire was developed and deployed using Research 
Electronic Data Capture (REDCap) tools12); a secure web 
application for building and managing online data collection 
exercises, hosted at the University of Bristol. Paper question-
naires were designed, scanned and verified using Teleform 
data capture software (version 16.5 (19) 22/10/2018). As this 
COVID-19 questionnaire was part of the usual ALSPAC annual 
data collection strategy for G1 we did not collect data from 
parents of G2 children not enrolled as G1 offspring (i.e., G1 
partners).
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Content design
Content for our fourth questionnaire was selected to address 
three needs:
1.  The need to track changes in health and wellbeing 
over time using repeated measures. To address this, 
we repeated a panel of questions from our previous 
questionnaires (e.g., health symptoms, recent contacts, 
mental health). By repeating questions, we are also 
able to capture information about participants who did 
not complete the previous COVID questionnaires.
2.  The need to harmonize data collection with other 
cohorts to facilitate co-ordinated analyses as part of the 
National Core Studies Longitudinal Health and Wealth 
work programme. We addressed this by incorporat-
ing content from a coordinated and freely available 
COVID-19 questionnaire co-developed by ALSPAC. 
This questionnaire was developed in consultation 
with a network of UK and international longitudi-
nal population studies and partners through a process 
facilitated by Wellcome.
3.  The need to gather data to investigate specific hypoth-
eses which could not be tested using the previous 
questionnaires. These topics were suggested by our 
collaborators and are detailed below.
The questionnaire included six sections, and captured informa-
tion on the following (if the questions come from a standard-
ised questionnaire, the source and reference has been provided 
in brackets; questions asked repeated from previous COVID-19 
questionnaires have been noted in brackets as well):
1.  Ethnicity
•     Information on ethnicity, based on categories used 
by the Office for National Statistics (note that this 
was part of the standard ‘Life@28’ annual ALSPAC 
questionnaire for G1 participants, not part of the 
COVID sections, but has been included here for 
comparison with the G0 generation)
2.  Health
•     Symptoms of COVID-19 and negative control 
symptoms since October 2020 (symptoms repeated 
from Q1, Q2 and Q3)
•     Diagnosis with COVID-19 (repeated from Q1, Q2 
and Q3) and details of symptoms (if infected)
•     Other health-related issues (restricting physical 
activities, shortness of breath) and further questions 
about long COVID, including cognitive/concentration 
issues
3.  Your lifestyle
•     Eating habits before and during lockdown (some 
questions repeated from Q2)
4.  Impact of the pandemic on feelings
•     Depression assessed using the Short Mood and 
Feelings Questionnaire (SMFQ;13; repeated from Q1 
and Q2) 
•     Anxiety assessed using the General Anxiety 
Disorder-7 questionnaire (GAD7;14; repeated from 
Q1 and Q2)
•     Well-being assessed using the Warwick-Edinburgh 
Mental Wellbeing Scales (WEMWBS;15; repeated 
from Q1 and Q2)
•     Perception of risk (repeated from Q2)
•     Coping with life
•     Obsessive compulsive symptoms assessed using five 
items from the Obsessive-Compulsive Inventory- 
Revised16 (of the original 18 items in this scale, 
five were chosen that loaded highest in the factor 
analysis of the original measure)
•     Reactions to stressful situations assessed using the 
Perceived Stress Scale17
•     Whether key life events occurred since March 
2020, and affect this had on participant
•     Free text inviting participants to provide details of 
other ways they have been affected by the pandemic
5.  Healthcare use
•     Whether medical treatments or appointments have 
been cancelled or postponed during the COVID-19 
pandemic, who cancelled them, and how worried 
participants were about this
•     Whether participant has developed signs or symp-
toms during the pandemic, whether they contacted 
a GP or healthcare professional, and how worried 
participants were about this
•     Thoughts about getting COVID-19 vaccine, and 
reasons for wanting or not wanting a vaccine
•     Effect of pandemic on plans to have children 
(G1 only; repeated from Q1)
6.  Living, working and earning
•     Current living arrangements (repeated from Q2)
•     Whether living arrangements have changed since 
July 2020 (repeated from Q2)
•     Current employment circumstances (repeated from Q2)
•     Days spent working from home in past week and 
before COVID-19
•     Managing financially
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•     Social contacts and methods of communication 
(repeated from Q1 and Q2)
The final questionnaire (REDCap PDF) used is available with 
the associated data dictionary (which includes frequencies 
of all variables that are available) as Extended data18.
Invitation and reminder strategy
Unlike previous ALSPAC COVID questionnaires, the invitation 
and reminder strategies differed for G0 and G1 cohorts, so 
will be explained here in turn. In all cases, participants were 
not contacted if our administrative database record indicated 
that they were deceased, had withdrawn from the study, 
had declined further contact or had declined to complete 
questionnaires.
On the 26th and 27th November 2020, all G0 participants for 
whom we had an active email address were sent an invitation 
to complete the questionnaire (n=6,721; note that this includes 
12 G0 mother participants sent a questionnaire after this date as 
a result of outreach work undertaken by the ALSPAC team). 
On the 10th December 2020 and 6th January 2021, any non- 
responders were sent a reminder email or text respectively 
to complete the questionnaire, and a final text message was 
sent on 22nd January 2021 to those for whom we had a current 
mobile phone number. The questionnaire survey was live on the 
online platform for nearly three months, with G0 questionnaire 
data collection turned off on 7th February 2021.
All G1 participants with an active email address or known 
home address, and who had not withdrawn from the study, 
were sent an invitation to complete the online questionnaire on 
2nd December 2020 (n=9,123; including five G1 participants 
sent a questionnaire after this date as a result of outreach work 
undertaken by the ALSPAC team). On the 15th December 
2020 and 5th January 2021, any non-responders were sent a 
reminder email to complete the online questionnaire. As part 
of our general questionnaire strategy, and in an effort to reduce 
paper printing, we elected to only send paper-based question-
naires to those participants who were deemed more likely to 
complete on paper. We defined this as participants who had 
completed at least one of the last three annual questionnaires 
on paper. Just over 1,000 paper questionnaires were sent out 
on 6th January 2021. A letter was sent between 18th and 22nd 
January and finally a text reminder on the 29th January to non- 
responders. The questionnaire was live on the online platform 
for nearly three months, with G1 questionnaire data collection 
turned off on 15th February 2021. ALSPAC stopped counting 
paper questionnaires on 19th March 2021.
In addition, traditional (print, radio, television) and social 
media (Facebook, Instagram and Twitter) were used to inform 
participants that the questionnaire was live, asking them to 
contact us if they had not received it and to encourage comple-
tion. These communication channels were also used to encourage 
re-engagement of friends and family back into the study. Unlike 
our standard questionnaires (usually completed annually), 
we did not provide any incentive for G0 completion. As the 
fourth COVID questionnaire was embedded within the wider 
annual questionnaire, G1 participants were offered an incen-
tive (a £10 shopping voucher) for returning a questionnaire. 
For both G0 and G1, we offered a prize draw (three prizes of 
£100) for those who completed their questionnaire by 31st 
January 2021 (for G0 participants) or 7th February 2021 (for 
G1 participants).
Response rate
A total of 15,844 invitations were sent out and responses 
were received from 8,643 participants (overall response rate 
of 55%).
As with our previous COVID questionnaires, female G1 par-
ticipants were much more likely to respond than male G1 par-
ticipants. Table 1 summarises the response rate within each group 
organised by cohort structure. Response rate amongst G0s was 
higher for the fourth questionnaire (64%; 4,273/6,721) compared 
to the first (57%; 3,720/6,393) and second (58%; 3,678/6,467). 
Response rate for the G1 cohort (48%; 4,370/9,123) was slightly 
higher than for the second COVID-19 questionnaire (44%; 
2,711/6,148), but lower than response to the first questionnaire 
(51%; 2,973/5,842). At face value, the £10 gift voucher incen-
tive for G1s did not appear to increase response rates for this 
questionnaire. However, this may be explained by the fact that 
earlier COVID-19 questionnaires only went out to those with 
valid email addresses, whereas this questionnaire was also 
sent to G1 participants via post, meaning this fourth COVID-
19 questionnaire was sent to a larger sample of G1 participants. 
These ‘new’ participants may be less engaged with the study, and 
hence less likely to return a questionnaire, which may balance 
out the benefit of having an incentive. Supporting this idea, if we 
split the G1 data according to whether they were sent an invi-
tation for the second COVID-19 questionnaire, of the 6,143 
participants who were sent both the second and fourth COVID-19 
questionnaire invitations, 4,005 (65%) returned the fourth 
COVID-19 questionnaire. In contrast, of the 2,980 partici-
pants who were not invited to complete the second COVID-19 
Table 1. Number of participants who were eligible and 
who responded to the fourth COVID-19 questionnaire 
(Q4).
Cohort Group Eligible1 Responded to Q42
G0 Mothers 4852 3101 (64%)
G0 Fathers/partners 1869 1172 (63%)
G1 Offspring daughters 4925 2883 (59%)
G1 Offspring sons 4198 1487 (35%)
TOTAL 15844 8643 (55%)
1G0 eligibility criteria (online questionnaires only): valid email 
address, marked as contactable for questionnaires; G1 eligibility 
criteria (online and paper questionnaires): marked as contactable 
for questionnaires.
2 Proportions of those invited (i.e. eligible).
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questionnaire but were invited to complete the fourth COVID-19 
questionnaire, only 365 (12%) returned one.
Of the 8,643 respondents, 2,012 (23%) had not returned a pre-
vious COVID questionnaire, 3,575 (41%) had returned all 
three of the previous COVID questionnaires, with 3,056 (35%) 
returning one or two (but not all three) of the previous COVID 
questionnaires (Table 2). Of those who returned a fourth COVID 
questionnaire, G1 participants were more likely to have not 
completed a previous COVID questionnaire (31% of G1s, vs 
16% of G0 mothers and 15% of G0 fathers/partners).
Key results
Characteristics of responders according to key variables that 
will be released with the complete dataset can be seen in 
Table 3. The population who responded were predomi-
nantly white (> 96%) and the majority had at least A-level 
qualifications (optional exams in the UK sat at the age of 18 
years), with 54% of G0 mothers, 70% of G0 partners/fathers 
and 74% of G1 offspring in this category. G0 partners/fathers 
were three years older on average than G0 mothers (61.5 years 
vs 58.6 years), with G1 offspring having an average age of 
28.4 years.
As with the previous questionnaires, participants were 
asked whether they thought they have had COVID-19. Options 
were: ‘Yes, confirmed by a positive test’, ‘Yes, suspected by 
a doctor but not tested’, ‘Yes, my own suspicions’ or ‘No’. 
In the fourth questionnaire, 300 (3.5%) respondents reported 
that they had tested positive to COVID-19, 110 (1.3%) reported 
that COVID-19 was suspected by a doctor but not tested and 
759 (8.8%) believed they had COVID-19 due to their own 
suspicions. Table 4 summarises the responses to this question 
by cohort structure.
Table 2. Number of participants who responded to the fourth COVID-19 questionnaire and whether they 
completed previous ALSPAC COVID-19 questionnaires.
Previous COVID-19 questionnaires G0 mothers G0 fathers/ 
partners
G1 offspring Total
No previous COVID-19 data 489 (16%) 174 (15%) 1349 (31%) 2012 (23%)
Returned one or two (but not all three) previous COVID-19 
questionnaires
1564 (50%) 562 (48%) 1449 (33%) 3575 (41%)
Returned all three previous COVID-19 questionnaires 1048 (34%) 436 (37%) 1572 (36%) 3056 (35%)
TOTAL 3101 1172 4370 8643
Table 3. Summary of key characteristics for those who responded to the fourth COVID questionnaire; n (%) 
for categorical variables or mean (sd) for continuous variables. The sample size for each characteristic is given 
in brackets after the % (for categorical variables) or sd (for continuous variables). Total sample sizes are 3,101 for G0 
mothers, 1,172 for G0 fathers/partners, and 4,370 for G1 offspring.
Key characteristic G0 Mothers G1 Fathers/ 
partners
G1 Offspring
Age (years) 58.6 (4.4; n = 3,101) 61.5 (5.15; n = 1,172) 28.4 (0.53; n = 4,3664)
Latest BMI1 26.4 (5.11; n = 2,459) 27.46 (4.04; n = 896) 24.6 (5.15; n = 3,553)
Latest systolic BP1 119.6 (14.3; n = 2,449) 132.8 (13.21; n = 904) 116 (11.28; n = 3,485)




1593 (53.8%; n = 2,962)
 
776 (69.8%; n = 1,112)
 
2296 (73.6%; n = 3,118)
Ethnicity (from baseline ALSPAC)3 
White
 
2900 (98.2%; n = 2,953)
 
1098 (98.7%; n = 1,112)
 
3740 (96.3%; n = 3,885)
Ethnicity (from COVID questionnaire) 
White
 
3033 (98.0 %; n = 3,096)
 
1150 (98.3%; n = 1,170)
 
4182 (95.8%; n = 4,362)
1Data taken from the most recent clinic that individual attended where available.
2Data taken from pregnancy questionnaires for G0 and from most recent questionnaire for G1 where available.
3Data taken from pregnancy questionnaires for all.
4This sample size is lower than the total number of G1’s who returned a questionnaire (n = 4,370) as data for four triplet/quadruplet 
pregnancies have been coded as missing in the release dataset for confidentiality reasons.
BMI, body mass index; BP, blood pressure; sd, standard deviation.
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As with the previous questionnaires, we applied the algo-
rithm derived by Menni and colleagues19 to predict ‘prob-
able infection’ using data collected from an app-based symptom 
tracker20. This algorithm uses four symptoms: loss of smell and 
taste, severe or significant persistent cough, severe fatigue and 
skipped meals (coded as 1 if present and 0 otherwise), together 
with age and sex (1 male; 0 female). We had slight differences 
in wording and thus the algorithm (using the same weightings) 
applied was as follows:
  -1.32 - (0.01 x age) + (0.44 x sex) + (1.75 x loss of loss 
of smell or taste)
 + (0.31 x new persistent cough) + (0.49 x severe fatigue)
 + (0.39 x decreased appetite). 
Probable COVID-19 cases were obtained by applying an 
exp(x)/[1+(exp(x)] transformation and coding values >0.5 as 
probable cases. We applied this algorithm to our monthly symp-
tom data collected in questionnaire 4 which asked about symp-
toms experienced from October 2020 until February 2021. 
The proportion of predicted cases decreased slightly over time, 
with 1.9% and 2.3% of predicted cases in October and Novem-
ber 2020, respectively, and 1.6–1.8% of predicted cases in 
December 2020 to February 2021 (Figure 1). These monthly 
percentages are lower than the peak in March 2020 (4.2%) 
observed from our first COVID-19 questionnaires7. Combin-
ing all of the questionnaire 4 data together, 359 of 8,587 (4.2%) 
of participants were predicted to be COVID-19 cases between 
October 2020 and February 2021. As with our previous use of this 
algorithm, we note that these predictions are subject to impor-
tant assumptions, which we discussed in more detail in our pre-
vious data notes7,8: 1) the baseline risk of having COVID-19 
(intercept term) is the same as in the Menni study population; 
2) the slight difference in the wording of symptoms captures 
the same information as those in the Menni study; and 3) the 
Table 4. Participant response to whether they have had COVID-19 from the fourth 
COVID-19 questionnaire.
G0 mothers G0 partners/ 
fathers
G1 offspring Total
Yes, positive test 69 (2.3%) 26 (2.2%) 205 (4.7%) 300 (3.5%)
Yes, doctor suspected, no test 33 (1.1%) 10 (0.9%) 67 (1.5%) 110 (1.3%)
Yes, own suspicions 205 (6.7%) 97 (8.4%) 457 (10.5%) 759 (8.8%)
No 2757 (90%) 1026 (88.5%) 3631 (83.3%) 7414 (86.4%)
Figure 1. Predicted cases (% of population) of COVID-19 per month according to symptoms reported for those months using 
the Menni et al. algorithm19.
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association of these symptoms with COVID-19 (fixed-effect 
terms) are the same as in the Menni study population.
As these data have been collected repeatedly, we can com-
bine these results across each of the COVID questionnaires. For 
self-reported COVID-19 status, of those who completed 
this question for any of the four COVID questionnaires, 499 
participants (5.1%) have either had a positive test or a doc-
tor suspected that they had had COVID-19. G1s were more 
likely to report having had a positive COVID-19 test or doctor- 
suspected symptoms, compared to the G0 generation (Table 5). 
If we include ‘own suspicions’ in our case definition of 
COVID-19 infection, the number of participants who may have 
had COVID-19 increases to 2,231 (23.0%). Similar analyses 
based on predicted COVID-19 cases from the Menni algorithm 
from March 2020 onwards show that 961 (9.9%) were pre-
dicted cases. These results are broadly similar – albeit slightly 
lower – if we restrict our analysis to those who responded to all 
four COVID questionnaires; by doing so we remove any poten-
tial bias due to: i) differences in COVID-19 testing, since wide-
spread testing was not available during the time of the first 
COVID-19 questionnaire; and ii) the time available to be 
infected, which could bias results if only including those who 
responded to the early COVID questionnaires (Table 5).
To assess potential reasons for non-completion of the fourth 
COVID questionnaire, which could bias comparisons between 
questionnaire waves, we explored whether various sociodemo-
graphic factors were associated with returning the fourth COVID 
questionnaire, but not any of the previous three (to explore 
who these ‘new’ participants were). Results are displayed in 
Figure 2. Returning only the fourth questionnaire was strongly 
associated with age/generation such that younger/G1 partici-
pants were much more likely to have only returned Q4 (most 
likely a result of the different G1 data collection strategy, which 
included mailing paper invitations to participants, and hence 
invited additional G1 participants not invited to the previous 
COVID-19 questionnaires). After adjusting for generation (G0 
vs G1), response to only the fourth COVID questionnaire was 
associated with several factors: male participants, those with 
lower educational attainment (a proxy for socioeconomic posi-
tion), and participants with an ethnicity other than white were 
more likely to only have fourth COVID questionnaire data. 
Participants who only returned the fourth COVID questionnaire 
were also more likely to self-report that they either had a posi-
tive COVID-19 test or had their own suspicions they had 
had COVID-19, relative to a reference group of ‘not had 
COVID-19’ (no difference for ‘doctor suspected COVID-19 infec-
tion’ was reported). These participants were also more likely to 
be a predicted COVID-19 case, based on their reported symp-
toms, using the Menni algorithm19. Few differences in physi-
cal or mental health were noted, although participants who only 
completed the fourth COVID questionnaire had higher systolic 
blood pressure, and a somewhat elevated risk of potential 
depression.
Strengths and limitations of the data
This data collection has a number of strengths. Firstly, the time-
lines within which the collection occurred allows comparisons to 
be made between the stringent mitigation measures early on in 
the pandemic and later easing of lockdown measures; users 
should ensure they are aware of completion dates for this data-
set, as England went into second national lockdown between 
5th November and 2nd December 2020, and a third national lock-
down again on January 6th 2021 (with local tiered restrictions 
between these dates).
Secondly, the availability of repeat data obtained over time 
throughout the pandemic, along with pre-pandemic baseline 
measures, allows assessment of longitudinal changes in health 
and wellbeing. For example, we have already been able to dem-
onstrate the short-term impact the pandemic has had on men-
tal health during the first lockdown in April–June 20201,21. This 
is the fourth ALSPAC COVID-19 questionnaire, meaning there 
is a wealth of longitudinal data to draw upon to explore the 
impact of the COVID-19 pandemic and its management on pop-
ulation health. These questionnaires are also supplemented by 
serology testing9 (with further testing currently being conducted 
[as of April/May 2021]), linking to Public Health England 
Pillar testing records11, and targeted data collections (such as a 
long COVID-specific questionnaire currently in development).
Thirdly, the alignment of measures with other UK studies pro-
vides potential for cross-cohort comparisons. This was achieved 
through the set of core questions developed by the Wellcome 
coordinated group and has already facilitated a co-ordinated 
analysis of mental health measures in ALSPAC and Generation 
Scotland1. ALSPAC is currently working on several cross-cohort 
Table 5. Self-report and predicted COVID-19 cases across all four COVID questionnaires.
Sample G0 mothers G0 partners/ 
fathers
G1 offspring Total
Self-reported positive test OR doctor 
suspected
Answered any COVID Qs 135 (3.84%) 45 (3.33%) 319 (6.60%) 499 (5.14%)
Answered all four COVID Qs 58 (4.06%) 17 (2.84%) 114 (5.77%) 189 (4.72%)
Self-reported positive test OR doctor 
suspected OR own suspicions
Answered any COVID Qs 719 (20.43%) 258 (19.08%) 1254 (25.94%) 2231 (22.98%)
Answered all four COVID Qs 260 (18.22%) 82 (13.69%) 499 (25.27%) 841 (21.02%)
Predicted cases based on symptoms 
(from March 2020 onwards)
Answered any COVID Qs 256 (7.27%) 107 (7.91%) 598 (12.37%) 961 (9.90%)
Answered all four COVID Qs 80 (5.60%) 39 (6.51%) 235 (11.89%) 354 (8.84%)
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projects to better understand the impact of the COVID-19 pan-
demic, including long COVID (NIHR funded CONVALESENCE 
study), cardiovascular health (COVIDITY), and longer-term 
mental health outcomes (COVID-19 National Core Studies 
[NCS]), among others.
Finally, we achieved an excellent response rate despite the 
lack of incentive in G0 and calling on our participants to take 
part in data collection for the fourth time in less than a year. 
As we have described previously, it should be noted that our 
online-only strategy will likely have affected response rates 
from our G0 mothers who historically have tended to use paper 
questionnaires more than other sub-groups when completing 
questionnaires and for whom we are least likely to hold a cur-
rent email address. However, the pandemic has led to a number 
of participants reaching out and getting in touch to provide 
these details, and indeed to re-engage with the study having 
dropped out previously. In addition, members of the study 
team have been contacting participants to ensure we have up 
to date email addresses. Throughout the pandemic, ALSPAC 
has also conducted outreach work to encourage participation of 
‘disengaged’ study participants.
A key limitation of this data collection is that, in some cases, 
the data recorded is potentially identifiable. As with previous 
COVID-19 questionnaires, we have gone through each indi-
vidual variable and made decisions as to whether we need to 
combine categories. This has only been carried out where we 
believe the data provides a high risk of potential disclosure 
(as detailed in the supplementary documentation file). Another 
limitation is that the response rate was non-random with regard 
to age, sex and socio-economic status; this could potentially 
introduce bias into analyses22. We acknowledge there is a risk 
for people with severe COVID-19 to be under-represented in the 
study if they were too unwell to respond to questionnaires. The 
reverse may also be true, however; participants who have had 
Figure 2. Forest plot describing the factors predicting returning the fourth COVID questionnaire, if none of the previous 
questionnaires were returned. All results are odds ratios from logistic regression models with ‘only returned questionnaire 4’ as the 
outcome (n = 8,643; n ‘only returned COVID questionnaire 4’ = 2,012; n ‘returned questionnaire 4 and at least one other previous COVID 
questionnaire’ = 6,631). Other than ‘age’, ‘generation’ and ‘participant’ (which are univariable models), all models adjusted for ‘generation’ (G0 
vs G1). Results to the right of the dashed line indicate an increased odds of only returning questionnaire 4 relative to the reference category, 
while results to the left indicate a decreased odds. The x-axis is on a logarithmic scale. Sample sizes and percentage of missing data: Age 
(n = 8,639; % missing = 0.05%); Generation (n = 8,643; % missing = 0.0%); Participant cohort (n = 8,643; % missing = 0.0%); Sex (n = 8,643; % 
missing = 0.0%); Education (n = 7,190; % missing = 16.8%); Ethnicity (n = 7,950; % missing = 8.0%); Self-reported COVID-19 status (n = 8,583; 
% missing = 0.7%); Predicted COVID-19 case from symptoms (n = 8,587; % missing = 0.7%); BMI (n = 6,903; % missing = 20.1%); Systolic blood 
pressure (n = 6,835; % missing = 20.9%); Diastolic blood pressure (n = 6,835; % missing = 20.9%); SMFQ (n = 8,236; % missing = 4.7%); GAD-7 
(n = 8,330; % missing = 3.6%); WEMWBS well-being (n = 8,260; % missing = 4.4%). BMI, body mass index; BP, blood pressure; CI, confidence 
interval; CSE, Certificate of Secondary Education; GAD-7; General Anxiety Disorder-7 questionnaire; GCSE, General Certificate of Education; 
SMFQ, Short Moods and Feelings Questionnaire; SD, standard deviation; WEMWBS, Warwick-Edinburgh Mental Wellbeing Scales.
Page 9 of 12
Wellcome Open Research 2021, 6:155 Last updated: 16 JUN 2021
COVID-19 (or believe that they have), may be more engaged 
with this research given their personal experience. For instance, 
in the first serology test (COVID questionnaire 3), partici-
pants who previously self-reported that they had had COVID-
19 were more likely to participate in this research9. We will be 
investigating this further using linkage to health records. 
Finally, we acknowledge that the predicted case status will 
contain measurement error. We will address this by providing 
more accurate measures of COVID-19 status in the future using a 
combination of serological testing and data linkage11.
In summary, this ALSPAC data obtained during the first year 
of the COVID-19 pandemic will enable researchers to capture 
changes in many aspects of people’s lives as we optimistically 
consider the pandemic abating and national mitigation strategies 
continuing to reduce. These data are available for researchers 
as described below.
Consent
Completion of the questionnaire was optional and choosing 
to complete the questionnaire is considered informed consent 
for the questionnaire. 
Ethical approval for the study was obtained from the ALSPAC 
Ethics and Law Committee and the Local Research Ethics 
Committees. Informed consent for the use of data collected via 
questionnaires and clinics was obtained from participants fol-
lowing the recommendations of the ALSPAC Ethics and Law 
Committee at the time. Study participants have the right to 
withdraw their consent for elements of the study or from the 
study entirely at any time. Full details of the ALSPAC consent 
procedures are available on the study website.
Data availability
Underlying data
ALSPAC data access is through a system of managed open 
access. The steps below highlight how to apply for access to the 
data included in this data note and all other ALSPAC data:
1. Please read the ALSPAC access policy which describes 
the process of accessing the data and samples in detail, and 
outlines the costs associated with doing so.
2. You may also find it useful to browse our fully searchable 
research proposals database, which lists all research projects that 
have been approved since April 2011.
3. Please submit your research proposal for consideration by the 
ALSPAC Executive Committee. You will receive a response 
within 10 working days to advise you whether your proposal 
has been approved.
Please note that a standard COVID-19 dataset will be made 
available at no charge (see description below); however, costs 
for required paperwork and any bespoke datasets required 
additional variables will apply.
Extended data
Open Science Framework: ALSPAC COVID-19 Data collections. 
https://doi.org/10.17605/OSF.IO/RM7HU18.
This project contains the following extended data:
•  ALSPAC_COVID_varlist.pdf (List of variable names 
and labels)
This project contains the following extended data within the folder 
‘Questionnaire 4’:
•  ALSPAC COVID Q4 FINAL (G0).pdf (REDCap PDF of 
final G0 questionnaire)
•  ALSPAC COVID Q4 FINAL (G1).pdf (REDCap PDF of 
final G1 questionnaire)
•  ALSPAC COVID Q4 data dictionary.pdf (Associated 
data dictionary including frequencies of all variables 
that are available)
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
COVID-19 Questionnaire 4 Data File
Data from the fourth ALSPAC COVID-19 questionnaire is 
available in two ways.
1.  A freely available standard set of data containing all 
participants together with key sociodemographic vari-
ables (where available) is available on request (see 
data availability section). This dataset also includes 
data obtained from the previous COVID questionnaires. 
Subject to the relevant paperwork being completed 
(costs may apply to cover administration) this data-
set will be made freely available to any bona fide 
researcher requesting it. Variable names will follow the 
format covid4_xxxx where xxxx is a four-digit number. 
A full list of variables released is available as Extended 
data18. Frequencies of variable and details of any 
coding/editing decisions and derived variables are also 
available in the data dictionary as Extended data18.
2.  Formal release files have been created for G0 moth-
ers, G0 fathers and G1 participants in the usual way 
and now form part of the ALSPAC resource. These 
datasets (or sections therein) can be requested in the 
usual way. Variable names will replicate those in 1) above 
but as each variable in ALSPAC is uniquely defined 
we have added markers to denote the source of the 
variable. For example, in the fourth COVID-19 ques-
tionnaire dataset, the age of the participant at comple-
tion (in years) is denoted by covid4_9650. In the G0 
mother’s dataset this will be denoted by covid4m_9650, 
for G0 fathers/partner this will be covid4p_9650 and 
for the G1 generation it will be covid4yp_9650. Fre-
quencies for all variables for each participant group 
are available in the data dictionary in the usual 
way.
Text data and other potentially disclosive information will not 
be released until they have been coded appropriately. Table 6 
describes the data that is withheld at the time of first release. 
Data will be incorporated back into both file sets as they become 
available.
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Section 1 - Ethnicity
B1_otherWhite Details of other white background
B1_otherMixed Details of other mixed/multiple ethnic background
B1_otherAsian Details of other Asian background
B1_otherBlack Details of other Black/African/Caribbean background
B1_other Details of other ethnic group
Section 2 – Health
2a Date told or when first thought had COVID-19
2h Details of new condition, illness or disability as a consequence of infection with coronavirus/COVID-19
Section 4 – Impact on your feelings during the pandemic
9 Is there anything else you would like to tell us about how the pandemic has affected you?
Section 5 – Healthcare use
1a Details of other medical treatments of appointments cancelled or postponed
3a Other reason don’t want to get vaccinated against COVID-19
3b Other reason do want to get vaccinated against COVID-19
Section 6 – Living, working and earning
1a_v Details of other family member(s) live with
1a_viii Details of other people live with
2a Details of other change in living arrangements since July 2020
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